Scholarly Works per year
Scholarly Works per year
Search results
-
2023
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib (Nature Communications, (2023), 14, 1, (4444), 10.1038/s41467-023-40061-y)
Coombes, R. C., Howell, S., Lord, S. R., Kenny, L., Mansi, J., Mitri, Z., Palmieri, C., Chap, L. I., Richards, P., Gradishar, W., Sardesai, S., Melear, J., O’Shaughnessy, J., Ward, P., Chalasani, P., Arkenau, T., Baird, R. D., Jeselsohn, R., Ali, S. & Clack, G. & 3 others, , Dec 2023, In: Nature communications. 14, 1, 4741.Research output: Contribution to journal › Comment/debate › peer-review
Open Access